The adjuvanticity of an O. volvulus-derived rOv-ASP-1 protein in mice using sequential vaccinations and in non-human primates.
Adjuvants potentiate antigen-specific protective immune responses and can be key elements promoting vaccine effectiveness. We previously reported that the Onchocerca volvulus recombinant protein rOv-ASP-1 can induce activation and maturation of naïve human DCs and therefore could be used as an innat...
Main Authors: | Jing Wang, Nancy Tricoche, Lanying Du, Meredith Hunter, Bin Zhan, Gaddam Goud, Elizabeth S Didier, Jing Liu, Lu Lu, Preston A Marx, Shibo Jiang, Sara Lustigman |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3355165?pdf=render |
Similar Items
-
Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans.
by: Parakkal Jovvian George, et al.
Published: (2019-09-01) -
The Onchocerca volvulus cysteine proteinase inhibitor, Ov-CPI-2, is a target of protective antibody response that increases with age.
by: Fidelis Cho-Ngwa, et al.
Published: (2010-08-01) -
Drugs that target early stages of Onchocerca volvulus: A revisited means to facilitate the elimination goals for onchocerciasis.
by: Shabnam Jawahar, et al.
Published: (2021-02-01) -
Prediction and validation of the structural features of Ov58GPCR, an immunogenic determinant of Onchocerca volvulus.
by: Robert Adamu Shey, et al.
Published: (2018-01-01) -
Preliminary evaluations of 3-dimensional human skin models for their ability to facilitate in vitro the long-term development of the debilitating obligatory human parasite Onchocerca volvulus.
by: Christoph Malkmus, et al.
Published: (2020-11-01)